Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

CarieScan Indian Distribution Agreement

18th Apr 2011 07:00

RNS Number : 0580F
3D Diagnostic Imaging PLC
18 April 2011
 



For immediate release

18 April 2011

 

 

3D DIAGNOSTIC IMAGING PLC

("3D" or the "Company")

 

Exclusive Distribution Agreement for CarieScan PRO in India

 

 

3D, the developer and supplier of the CarieScan PRO, the award winning hand held device for the early detection and monitoring of dental caries (tooth decay) is pleased to announce that its subsidiary CarieScan Limited has signed an exclusive distribution agreement for India with Analytical and Medical Technologies ("AMT"). This follows the announcement last week of an agreement with Wisdom International Medical Science and Technology Co. Ltd for the Chinese Market.

 

AMT has 40 direct employees and distributes its products through 28 sub dealers across the country. The company has its main office located in Mumbai with a further 9 regional offices. AMT specialises in the importation of innovative high technology dental products from around the world. Training dental personnel on the use of these products is a key element of AMT's business success. The company has good contacts with the 270 dental colleges registered in India.

 

The expansion of dental education has been enormous over the past 10 years and in the coming years a further 27,000 new dentists (a number broadly equivalent to the number of dentists currently in practice in the UK) are anticipated to qualify out of the dental schools each year. Most of these dentists are expected to progress into private practice to meet the healthcare needs of an increasingly affluent Indian society.

 

No additional regulatory approvals are required for the CarieScan PRO to be offered for sale in India and an initial 30 units are expected to be shipped in the near future.

 

Commenting, Graham Lay, Chief Executive Officer of 3D said: "I am very pleased with this expansion of the Company's presence in the region. The potential for growth within the Indian market is believed to be significant and this is a welcome addition to our recent agreement covering China and to our other agreements covering the whole of North America as well as Germany, Austria, Switzerland and the UK in Europe. Discussions with potential distribution partners in other territories are on-going and we look forward to making further announcements in due course. "

 

Dr Anil Ramachandran, the director of AMT and himself a qualified dentist said: "CarieScan is an excellent addition to the product offering of AMT to its dentist customers in India. It is complimentary to many other products within our portfolio which require education and training of the clinician. The expansion of dental care in India is dramatic and we believe that the demand for improved diagnosis of dental diseases in India will be a part of this development. We are certain that CarieScan will be well received by both patients and clinicians as more preventive treatment programmes are offered."

 

ENDS

 

 

For further information please contact:

3D Diagnostic Imaging Plc

Graham Lay, CEO

+44 (0) 1624 679000

Oliver Cooke, FD

finnCap

 NOMAD & Broker

Geoff Nash

Henrik Persson

Stephen Norcross (broking)

+44 (0)20 7600 1658

Buchanan Communications

Financial PR

Diane Stewart

Carrie Clement

+44 (0) 0131 226 6150

+44 (0) 0131 226 4427

 

Notes to Editors

 

3D owns the protected rights to a technology platform with a number of significant potential commercial applications. Its first product to market is the CarieScan PROtm.

 

The CarieScan PROtm measures the presence of tooth decay earlier and more accurately than any other device on the market and is more than 90% accurate in detecting both sound and carious teeth, well ahead of other methods. It detects "hidden" decay, providing dental practitioners with the opportunity to arrest or even reverse decay, driving the trend towards preventative dental care.

 

The lightweight caries detection monitor not only offers best-in-class performance for decay detection but also allows easy monitoring of the effect of treatment regimes to show decay advancement or regression, thus enabling dentists to tailor treatment to the needs of the patient at a low cost. The CarieScan PROtm consists of a hand piece and a disposable sensor which is held against the tooth being examined in a process which takes approximately 4 seconds per tooth with the result displayed on the CarieScan PROtm.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGREAELXFSPFEFF

Related Shares:

Afriag Global
FTSE 100 Latest
Value8,275.66
Change0.00